Part:BBa_K4805008
pTDH3-BmeTC_Y167A,D373C-tTDH1-pTEF2-ERG20_F96W-tSSA1-pPGK1-BmeTC-tPGK1
Contents
description
ERG20 catalyzes the sequential formation of geranyl diphosphate (GPP) and farnesyl diphosphate (FPP). ERG20_F96W, as a F96W mutant can help increase the supply of FPP. BmeTC_Y167A, D373C refers to a variant of the Tetraprenyl-beta-curcumene Cyclase from Bacillus megaterium (Genbank Accession: CP001982.1, 2130781–2132658) that contains two specific mutations: Y167A and D373C. In a cell-free system, the synergistic effect of BmeTC_Y167A, D373C and BmeTC can reach 53.26% higher activity than BmeTC_Y167A, D373C. This inspired us to attempt to co-expressed BmeTC and BmeTC_Y167A, D373C in S.cerevisiae to produce ambrein (Tsutomu S. et al, 2020). It belongs to the terpenoids producing collection we create for the production of santalol and ambrein in S. cerevisiae, which includes BBa_K4805000-BBa_K4805012. This collection can provide inspiration and efficient methods to utilize the MVA pathway in S.cerevisiae for other teams.
usage and biology
ERG20 catalyzes the sequential formation of geranyl diphosphate (GPP) and farnesyl diphosphate (FPP). ERG20_F96W, as a F96W mutant can help increase the supply of FPP. BmeTC_Y167A, D373C refers to a variant of the Tetraprenyl-beta-curcumene Cyclase from Bacillus megaterium (Genbank Accession: CP001982.1, 2130781–2132658) that contains two specific mutations: Y167A and D373C. Although BmeTC can only catalyze the bicyclic structure at the end of squalene, its variant BmeTC_Y167A, D373C possess the ability of catalyzing both monocyclic and bicyclic structure, which can produce ambrein. Besides, it has a higher affinity for bicyclic substances(8α-hydroxypolypoda-13,17,21-triene) compared to squalene. In a cell-free system, the synergistic effect of BmeTC_Y167A, D373C and BmeTC can reach 53.26% higher activity than BmeTC_Y167A, D373C. This inspired us to attempt to co-expressed BmeTC and BmeTC_Y167A, D373C in S.cerevisiae to produce ambrein (Tsutomu S. et al, 2020).
source
composite
characterization
We tried to insert BmeTC_Y167A, D373C and BmeTC into 106 site to construct our strain Lv2a-1(Figure 1A), and the successful integration can be seen in strain as it is shown in Figure 1C.
Figure 1. (A) Schematic strategy of BmeTC_Y167A, D373C and BmeTC integration into the site 106. (B) Schematic strategy of BmeTC_Y167A, D373C-Flexible Linker-BmeTC integration into the site 106. (C) These two genes were confirmed to be inserted into site 106 in the strain 6 of Lv2a-1.(D) These two genes were confirmed to be inserted into site 106 in the strain 2-8 of Lv2a-2.
Unfortunately, we did not observe any peaks suspected of ambrein. But the reaction substrate, squalene, can be detected at 9.70-9.83 min. Compared with strain Lv1, the yield of squalene significantly decreased in the further modified strains. To be specific, the yield of squalene decrease up to 77.40% in strain Lv2a-1. Although there's no ambrein can be detected, the decrease of squalene might indicate the synthesis of some potential intermediates. We will optimize our testing method and the specificity of cyclase to reach the goal of ambrein production.Figure 2. (A) Analysis of ambrein and squalene, accumulated in strain Lv1, Lv2a-1 and Lv2a-2 by GC-MS. (B) The yield comparison of squalene in different strains based on GC-MS.
sequencing and features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1357
Illegal NheI site found at 6331 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 4112
Illegal BglII site found at 4173
Illegal BglII site found at 5638
Illegal BamHI site found at 760
Illegal BamHI site found at 5734
Illegal XhoI site found at 2567
Illegal XhoI site found at 4289 - 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 3828
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 4275
Illegal BsaI site found at 4536
Illegal BsaI.rc site found at 4525
Illegal BsaI.rc site found at 5648
reference
Yamabe, Y., Kawagoe, Y., Okuno, K., Inoue, M., Chikaoka, K., Ueda, D., Tajima, Y., Yamada, T. K., Kakihara, Y., Hara, T., & Sato, T. (2020). Construction of an artificial system for ambrein biosynthesis and investigation of some biological activities of ambrein. Scientific Reports, 10(1), 19643. https://doi.org/10.1038/s41598-020-76624-y
None |